Chronotherapy combining 5-fluorouracil, folinic acid and carboplatin as first line treatment in metastatic colorectal cancer. A phase 2 study;Chronothérapie associant le 5-fluorouracile, l'acide folinique, et le carboplatine en première ligne thérapeutique dans le cancer colorectal métastatique. Une étude de phase 2

Pathologie Biologie

Volumn 53, Issue 5, 2005, Pages 273-276

  Focan, C ^a   Kreutz, F ^b   Longree L ^a   Graas, M P ^a   Focan Henrard, D ^a   Moeneclaey, N ^a   David, A ^a   Biquet, J F ^a   Materne, R ^a   Weerts, J ^a   Delforge, M ^a  

^a Clinique Saint Joseph   (Belgium)

^b NONE

Author keywords

Ambulatory medicine; Carboplatine; Chronotherapy; Colorectal cancer

Indexed keywords

CARBOPLATIN; FLUOROURACIL; FOLINIC ACID;

ADULT; AGED; ALOPECIA; ARTICLE; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER SURVIVAL; CHRONOTHERAPY; CLINICAL TRIAL; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG INFUSION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; MUCOSA INFLAMMATION; NAUSEA; NEUROLOGIC DISEASE; PHASE 2 CLINICAL TRIAL; SKIN MANIFESTATION; TREATMENT OUTCOME; VOMITING;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CHRONOBIOLOGY; COLONIC NEOPLASMS; COLORECTAL NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOROURACIL; HUMANS; INFUSIONS, INTRAVENOUS; LEUCOVORIN; MALE; MIDDLE AGED; NEOPLASM METASTASIS; RECTAL NEOPLASMS; SURVIVAL ANALYSIS;

EID: 20444378181     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.patbio.2004.12.029     Document Type: Article

References (15)

1. D. Cunningham, S. Pyrhonen, and R.D. James Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer Lancet 352 1998 1413 1418
2. S. Giacchetti, B. Perpoint, and R. Zidani Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer. Classic Papers and Current Comments J. Clin. Oncol. 6 2002 885 897
3. L.B. Saltz, J.V. Cox, and C. Blancke Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group N. Engl. J. Med. 343 2000 905 914
4. C. Tournigand, T. Andŕ, and E. Achille Folfiri followed by Folfox 6 or the reverse sequence in advanced colorectal cancer: a randomized Gercor study J. Clin. Oncol. 22 2004 229 237
5. F. Ĺvi, R. Zidani, and J.M. Vannetzel Chronomodulated versus fixed infusion rate delivery of ambulatory chemotherapy with oxaliplatin, 5-fluoruracil and folinic acid in patients with colorectal cancer metastases. A randomized multi-institutional trial J. Natl. Cancer Inst. 86 1994 1608 1617
6. F. Ĺvi, R. Zidani, and J.L. Misset Randomized multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer Lancet 350 1997 681 686
7. J.J. Lokich, J.D. Ahlgren, and J. Cantrell A prospective randomised comparison of protracted infusional 5-fluorouracil with or without weekly bolus cisplatin in metastatic colorectal carcinoma Cancer 67 1991 14 19
8. C.D. Natoli, M.Y. Martino, and L. Irtelli Chronomodulated infusion of 5-fluorouracil, folinic acid and carboplatin in colorectal cancer: a pilot study Anticancer Res 15 1995 2841 2842
9. A. Gil, C. Dy, and O.F. Hidalgo Carboplatin (CBDCA) and 120 hours 5-fluorouracil (5:FU) in patients (PTS) with colorectal cancer 1987 Proc ECCO 4 42, abstract 161
10. C. Focan Rythms of cancer chemotherapy P. Redfern «: Chronotherapeutics:» 2003 Pharmaceutical Press 234 282 10
11. D.J. Kerr, C. Lewis, and B. O'Neil The myelotoxicity of carboplatin is influenced by the time of its administration Hematol. Oncol. 8 1990 59 63
12. C. Focan, F. Kreutz, N. Moeneclaye, and D. Focan-Henrard Étude randomiśe ́valuant la chronotoĺrance d'une association de 5-fluorouracile, acide folinique et carboplatine chez des patients porteurs d'un cancer pulmonaire non ̀ petites cellules (CPNPC) Pathol. Biol. 51 2003 204 205
13. C. Focan, F. Kreutz, D. Focan-Henrard, and N. Moeneclaey Chronotherapy with 5-fluorouracil, folinic acid and carboplatin for metastatic colorectal cancer; an interesting therapeutic index in a phase II trial Eur. J. Cancer 36 2000 341 347
14. F. Ĺvi, R. Zidani, and S. Brienza Multicenter evaluation of intensified ambulatory chronomodulated chemotherapy with oxaliplatin, fluorouracil and leucovorin as initial treatment of patients with metastatic colorectal cancer Cancer 85 1999 2532 2540
15. H. Cuŕ, V. Chevalier, and A. Adenis Phase II trial of chronomodulated infusion of high-dose fluorouracil and l-folinic acid in previously untreated patients with metastatic colorectal cancer J. Clin. Oncol. 20 2002 1175 1181